MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies

Maureen Joffe

HIVs Effects on Breast Cancer Treatment and Outcomes in South Africa

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri Breast

Franziska Michor

Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma Breast Brain, nervous system

Marcus E Peter

Fas protects cancer stem cells from death

Ovary Breast

Raymond F Muzic

Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials

Prostate Breast

Pediatric oncology or childhood cancer

Lalage Wakefield

Development of TGF-beta antagonists for cancer therapy

Breast

Tim Greten

Analysis of Cancer-Related Immune Suppressor Mechanisms in Mice

Breast

Fraser Symmans

Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer

Breast

Neil Johnson

Identifying BRCA1 protein variants that provide resistance to therapy

Ovary Breast

Nathan J Mcdannold

MRI-guided focused ultrasound for drug delivery and ablation of brain tumors

Breast Brain, nervous system